Presentation
13 March 2024 Monitoring distribution of the therapeutic agent dimethyl sulfoxide (DMSO) with hyperspectral excitation-resolved near-infrared fluorescence imaging
Author Affiliations +
Abstract
Dimethyl sulfoxide (DMSO) is one of the most commonly used pharmaceutical drugs in life sciences. It has a wide spectrum of pharmacological effects, including anti-inflammatory effects, local analgesia, weak bacteriostasis and most importantly membrane penetration. We recently developed novel hyperspectral excitation-resolved near-infrared fluorescence imaging system (HER-NIRF) based on a continuous-wave wavelength-swept laser. In this study, this technique is applied for measuring the distribution of the therapeutic agent dimethyl sulfoxide (DMSO) by utilizing solvatochromic shift in the spectral profile of albumin-bound Indocyanine green (ICG). Phantom experiments are conducted to evaluate the performance of the HER-NIRF system. The results show that the distribution of DMSO can be visualized in the wide-field reflection geometry.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Farouk Nouizi, Jaedu Cho, Chang-Seok Kim, and Gultekin Gulsen "Monitoring distribution of the therapeutic agent dimethyl sulfoxide (DMSO) with hyperspectral excitation-resolved near-infrared fluorescence imaging", Proc. SPIE PC12846, Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues XXII, PC128460J (13 March 2024); https://doi.org/10.1117/12.3005062
Advertisement
Advertisement
KEYWORDS
Therapeutic agents

Fluorescence imaging

In vivo imaging

Near infrared

Permeability

Reflection

Skin

Back to Top